1850Guangxi Medical Journal, A ug. 2018 $Vol. 40 ,No. 16
[13] PolakJF，P e n c i n a M J，P e n c i n a K M，etal.Carotid-wallinti-
ma-media thicknjs and cardiovascular events [J]. N Engl J
M e d，2011，365(3):213 -221.
[14] Rosvall M，Janzon L，Berglund G，et a l. Incident coronary
events and case fatality in relation to common carotid intima-
media thickness[J].J Intern M e d，2005,257(5):430 - 437. [15] Rundek T，Arif H，Boden-Albala B，et a l. Carotid plaque，a
subclinical precursor of vascular events ：the Nortliern M a n-
hattan Study [J]. Neurology，2008，70( 14): 1 200 -1 207. [16] Salonen J T，Salonen R. Ultrasonographically assessed carotid
morphologyandtheriskofcoronaryheartdisease[J].Arte-
rioscler T h r o m b，1991，11 (5) ：1 245 - 1 249.
[17] Storl^ S，van den Beld A W，von Schacky C，et a l. Carotid ar-
tery plaque burden，stiffness，and mortality risk in elderly
m e n：a pros;pective，population-based cohort study [J]. Cir-
culation ，2004,110(3) ：344 -348.
(上接第1827页）
[10]张国辉，郑清友，关亚伟，等.保留膀胱综合方法治疗肌
层浸润性膀胱癌的疗效评价[J].现代泌尿外科杂志，
2012，17(4) ：374 -376.
[11]沈捷，刘峡，张福泉，等.109例膀胱癌三维适形放疗临
床分析[J].中华放射肿瘤学杂志，2009，18(2):115 -119. [12] Sharma A，Mohanti B，Raina V，et a l. A phase "study of
gemcitabine and oxaliplatin (Oxigem)in unresectable gall
bladder cancer [J]. Cancer Ghemother Pharmacol，2010,65
(3) ：497 -502.
[13] Boukovinas I，Androulakis N，Kentepozidis N，et a l. C h e m o-
therapy with gemcitabine，cisplatin，and docetaxel in the
treatment for patients with muscle-invasive bladder cancer:a
multicenter phase "study of the Hellenic Oncolog R e-
search Group (H O R G) [J]. Cancer Chemot)ier Pharmacol，
2012,69(2) ：351 -356.
[14] Culine S，Flechon A，G u i o t A，et a l. Gemcitabine or gemcit-
abine plus oxalij^latin in the first-line treatment of patients
with advanced transitional cell carcinoma of the urothelium [18] Xie W，W u Y，W a n g W，et a l.A longitudinal study of carot-
id plaque and r i s l^ of ischemic cardiovascular disease in the
Chinese population [J]. J A m Soc Echocardiogr，2011，24
(7) ：729 -737.
[19] Chen P C，Jeng J S，Hsu H C，et a l. Carotid Atherosclerosis
Progression and Risl^ of Cardiovascular Events in a C o m m u-
nity in Tai-wan[ J]. Sci R e p，2016，6 ：25 733.
[20] Rosenfield K，Matsumura J S，Chaturvedi S，et a l. R a n d o m-
ized Trial of Stent versus Surger for Asymptomatic Carotid
Stenosis[ J] .N E n g l J M e d，2016,374(11) ：1 011 -1 020.
[21 ]Goff D C Jr，Loyd-Jones D M，Bennett G，et al.2013 A C C/A H A
guideline on the assessment of cardiovascular risk:a report
of tJe American College of Cardiolog/American Heart A s-
sociation Tasl^ Force on Practice Guidelines[J]. J A m Coll
Cardiol，2014,129(25 Pt B) ：2 935 -2 959.
(收稿日期:2018 -04 -05修回日期:2018 -07 -02)
unfit for cisplatin-based chemotherapy:a randomized phase 2
study of the French Genitourinary Tumor Group ( G E T U G
V01)[ J] .Eur Urol，2011，60(6) ：1 251 -1 257.
[15] Dinorcia J，L e M K，Reavey P L，et a. One hundred thirty re-
sections for pancreatic neuroendocrine tumor ：evaluating the
impact of minimally invasive and paenchyma-s;paring tech-
niques[ J].J Gastrointest Surg，2010，14( 10) ：1 536 -1 546.
[16] Solsona E，Climent M A，Iborra I，et a l. Bladder preservation
in selected patients with muscle-invasive bladder cancer by
complete transurethral resection of the bladder plus systemic
chemotherapy:long-termfollow-upofaphase2nonrandom-
ized comparative t r i a l with radical cystectomy [J ]. Eur Urol，2009,55(4):911 -919.
[17] Efstathiiou J A，Spiegel D Y，Shipley W U，et a l. Long-term
outcomes of selective bladder preservation by combined-mo-
dality therapy for invasive bladder cancer：the M G H experi-
ence[ J] .Eur Urol，2012，61 (4 )：705 -711.
(收稿日期:2018 -03 -14修回日期:2018 -06 -10)
參本刊对关键词标引的要求
为方便读者查找文献，利于文献检索特别是计算机自动检索，我刊要求每篇论文需标引2 ~5个关键词。关键词请尽量使用美国国立医学图书馆编辑的最新版《Index M e d i u s》中医学主题词表（M e S H)内所列的词。如果最新版M e S H中尚无相应的词，处理办法有：（1)可选用直接相关的几个主题词进行组配。（2)可根据树状结构表选用最直接的上位主题词。（3 )必要时，可采用习用的自由词并排列于最后。